Novem Group Regeneron Pharmaceuticals, Inc. Transaction History
Novem Group
- $713 Billion
- Q1 2025
A detailed history of Novem Group transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Novem Group holds 1,361 shares of REGN stock, worth $821,472. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,361
Previous 1,038
31.12%
Holding current value
$821,472
Previous $739 Million
16.73%
% of portfolio
0.12%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,481Shares Held
87.4MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.61 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.1 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.26 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.92 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.86 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...